Aceso Life Science Group Limited (0474.HK)
HKD 0.05
(0.0%)
HKD 0.05
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.73 Billion HKD | 16.81% |
| 2022 | 2.34 Billion HKD | -22.13% |
| 2021 | 3.01 Billion HKD | 9.1% |
| 2020 | 2.75 Billion HKD | 25.65% |
| 2019 | 2.19 Billion HKD | -10.03% |
| 2018 | 2.44 Billion HKD | 77.88% |
| 2017 | 1.37 Billion HKD | 25.16% |
| 2016 | 1.09 Billion HKD | 31.84% |
| 2015 | 831.51 Million HKD | 15.92% |
| 2014 | 717.35 Million HKD | 220.25% |
| 2013 | 224 Million HKD | 82.73% |
| 2012 | 122.58 Million HKD | 0.0% |
| 2011 | - HKD | -100.0% |
| 2010 | 217.83 Million HKD | -42.43% |
| 2009 | 378.37 Million HKD | 0.0% |
| 2008 | - HKD | -100.0% |
| 2007 | 8.96 Million HKD | 13076.47% |
| 2006 | 68 Thousand HKD | -93.69% |
| 2005 | 1.07 Million HKD | -34.69% |
| 2004 | 1.64 Million HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | 2.73 Billion HKD | 311.11% |
| 2023 Q1 | 685 Million HKD | -70.78% |
| 2023 Q2 | 2.26 Billion HKD | 231.24% |
| 2023 Q3 | 666 Million HKD | -70.65% |
| 2023 FY | 2.73 Billion HKD | 16.81% |
| 2022 Q4 | 2.34 Billion HKD | 210.05% |
| 2022 Q3 | 756 Million HKD | -65.32% |
| 2022 FY | 2.34 Billion HKD | -22.13% |
| 2022 Q1 | 789 Million HKD | -73.79% |
| 2022 Q2 | 2.18 Billion HKD | 176.3% |
| 2021 Q2 | 2.56 Billion HKD | 3.01% |
| 2021 FY | 3.01 Billion HKD | 9.1% |
| 2021 Q1 | 2.49 Billion HKD | -9.6% |
| 2021 Q4 | 3.01 Billion HKD | 251.23% |
| 2021 Q3 | 857 Million HKD | -66.64% |
| 2020 Q3 | 1.94 Billion HKD | -11.9% |
| 2020 Q1 | 1.41 Billion HKD | -35.42% |
| 2020 FY | 2.75 Billion HKD | 25.65% |
| 2020 Q4 | 2.75 Billion HKD | 41.71% |
| 2020 Q2 | 2.21 Billion HKD | 55.85% |
| 2019 Q2 | 2.25 Billion HKD | 30.67% |
| 2019 FY | 2.19 Billion HKD | -10.03% |
| 2019 Q4 | 2.19 Billion HKD | 57.07% |
| 2019 Q3 | 1.39 Billion HKD | -37.98% |
| 2019 Q1 | 1.72 Billion HKD | -29.33% |
| 2018 Q1 | 1.41 Billion HKD | 3.4% |
| 2018 Q4 | 2.44 Billion HKD | 37.85% |
| 2018 Q3 | 1.77 Billion HKD | -19.4% |
| 2018 Q2 | 2.19 Billion HKD | 54.84% |
| 2018 FY | 2.44 Billion HKD | 77.88% |
| 2017 Q4 | 1.37 Billion HKD | 158.53% |
| 2017 FY | 1.37 Billion HKD | 25.16% |
| 2017 Q3 | 530.72 Million HKD | -28.08% |
| 2017 Q2 | 737.97 Million HKD | 65.56% |
| 2017 Q1 | 445.73 Million HKD | -59.34% |
| 2016 Q2 | 718.91 Million HKD | 169.18% |
| 2016 Q4 | 1.09 Billion HKD | 331.86% |
| 2016 Q3 | 253.84 Million HKD | -64.69% |
| 2016 FY | 1.09 Billion HKD | 31.84% |
| 2016 Q1 | 267.07 Million HKD | -67.88% |
| 2015 FY | 831.51 Million HKD | 15.92% |
| 2015 Q3 | 255.84 Million HKD | -51.32% |
| 2015 Q4 | 831.51 Million HKD | 225.01% |
| 2015 Q2 | 525.52 Million HKD | 105.41% |
| 2015 Q1 | 255.84 Million HKD | -64.34% |
| 2014 Q2 | 271.86 Million HKD | 173.09% |
| 2014 FY | 717.35 Million HKD | 220.25% |
| 2014 Q4 | 717.35 Million HKD | 396.26% |
| 2014 Q1 | 99.55 Million HKD | -55.56% |
| 2014 Q3 | 144.55 Million HKD | -46.83% |
| 2013 Q4 | 224 Million HKD | 1500.0% |
| 2013 FY | 224 Million HKD | 82.73% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 Q2 | - HKD | 0.0% |
| 2013 Q3 | 14 Million HKD | 0.0% |
| 2012 Q2 | 147.45 Million HKD | 0.0% |
| 2012 FY | 122.58 Million HKD | 0.0% |
| 2012 Q1 | - HKD | -100.0% |
| 2012 Q3 | - HKD | -100.0% |
| 2012 Q4 | 122.58 Million HKD | 0.0% |
| 2011 Q2 | 511.58 Million HKD | 0.0% |
| 2011 Q4 | 638.05 Million HKD | 0.0% |
| 2011 FY | - HKD | -100.0% |
| 2010 Q4 | 217.83 Million HKD | 0.0% |
| 2010 Q2 | 330.86 Million HKD | 0.0% |
| 2010 FY | 217.83 Million HKD | -42.43% |
| 2009 FY | 378.37 Million HKD | 0.0% |
| 2009 Q4 | 378.37 Million HKD | 0.0% |
| 2008 FY | - HKD | -100.0% |
| 2007 FY | 8.96 Million HKD | 13076.47% |
| 2006 FY | 68 Thousand HKD | -93.69% |
| 2005 FY | 1.07 Million HKD | -34.69% |
| 2004 FY | 1.64 Million HKD | 0.0% |